Zydus Lifesciences shares witnessed a spike on Thursday after the company said its board will meet on May 19 to consider a share buyback. The stock also gained momentum as Zydus announced a $166 million acquisition of US-based Assertio. Investor sentiment improved on expectations of capital return and strategic business expansion.
Uday Kotak questions SpaceX valuation, says only time will tell if we’re in ‘mega bubble’
Uday Kotak described SpaceX’s blockbuster IPO as a test for capitalism, questioning whether investors are backing humanity’s future or fueling a massive bubble. His remarks